EphrinB2 inhibits cell proliferation and motility in vitro and predicts longer metastasisfree survival in breast cancer.
Int J Oncol
; 55(6): 1275-1286, 2019 Dec.
Article
in En
| MEDLINE
| ID: mdl-31638179
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast
/
Breast Neoplasms
/
Receptor, EphB4
/
Ephrin-B2
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Int J Oncol
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Sweden